Health & Fitness

According to FutureWise analysis, the market for bone cement mixers in 2023 is US$14.08 million, and is expected to reach US$22.22 million by 2031 at a CAGR of 5.90%. The bone cement mixer devices market is currently experiencing steady growth, largely fueled by the rising demand for orthopedic procedures and the aging global population, which faces increasing rates of degenerative bone diseases such as osteoarthritis and osteoporosis. These specialized devices are critical in orthopedic surgeries, as they facilitate the mixing of bone cement components—typically a combination of polymethylmethacrylate (PMMA) powder and liquid monomer—to achieve the optimal consistency and quality required for surgical applications. In 2024, the market for bone cement mixers demonstrated moderate yet consistent growth, which can be attributed to the surging number of orthopedic procedures. This trend underscores the essential role that these devices play in ensuring successful surgical ... Continue reading →

According to FutureWise analysis, the market for bone conduction devices is expected to reach US$19.4 billion by 2031 at a CAGR of 11.50%. Bone conduction devices represent an innovative approach to sound transmission by bypassing the traditional auditory pathways of the ear. Instead of directing sound through the ear canal and middle ear, these devices transfer sound vibrations directly to the cranial bones through a specialized interface known as a bone-conductive interface (BCI). This mechanism distinguishes them from conventional headphones, which rely on airwaves to deliver sound. One notable example of bone conduction technology is the BAHA, or bone-anchored hearing aid. This device is surgically implanted into the bone behind the ear and acts as a bridge for sound, making it particularly beneficial for individuals experiencing conductive or mixed hearing loss. Its detachable design allows for easy maintenance and user comfort, further enhancing the overall hearing experience. ... Continue reading →

According to FutureWise analysis, the market for bone densitometer systems in 2023 is US$1.2 billion, and is expected to reach US$2.13 billion by 2031 at a CAGR of 7.40%. The bone densitometer is a sophisticated X-ray technology utilized to assess bone loss by measuring bone mineral density (BMD). This tool plays a critical role in diagnosing conditions such as osteopenia and osteoporosis, as well as determining an individual's risk for fractures. The increasing global prevalence of osteoporosis and osteopenia has significantly heightened the demand for bone density meters. These devices are favored for their convenience, quick procedure times, and noninvasive nature, which eliminates the need for anesthesia. Physicians can leverage bone densitometry not only to diagnose osteoporosis but also to evaluate fracture risk, monitor treatment effectiveness, and ensure patient compliance with medication regimens. The axial bone densitometer specifically measures the bone density in the ... Continue reading →

Biopharmaceutical bio-separation systems play a crucial role in the isolation, purification, and refinement of biological molecules, such as proteins, antibodies, vaccines, and nucleic acids, from complex biological mixtures. These systems are fundamental to biopharmaceutical production, ensuring that therapeutic products comply with the rigorous purity, safety, and efficacy standards necessary for clinical application. Bio-separation processes are utilized throughout various stages of biopharmaceutical manufacturing, from the initial cell culture to the final product formulation. They address the challenge of effectively separating target biomolecules from impurities, which can include host cell proteins, DNA, and other contaminants. The primary objective of bio-separation systems is to achieve high purity and yield while preserving the biological activity of the target molecule. Key techniques employed in these systems include chromatography, filtration, centrifugation, and ... Continue reading →

According to FutureWise analysis the market for biopharmaceutical CMO And CRO in 2023 was US$ 34.38 billion, and is expected to reach US$ 55.3 billion by 2031 at a CAGR of 6.10%. A Contract Manufacturing Organization (CMO) plays a critical role in the pharmaceutical industry by providing a comprehensive range of drug development services specifically tailored to the manufacturing processes of pharmaceutical companies. By partnering with CMOs, major pharmaceutical firms can streamline their operations, allowing them to focus on essential aspects such as drug discovery, marketing, and regulatory compliance while outsourcing the complex and resource-intensive activities of production. CMOs are equipped with specialized technologies and expertise to handle various manufacturing needs, including formulation development, scale-up processes, and packaging, ensuring that products meet stringent quality standards and regulatory requirements. Conversely, a Contract Research Organization (CRO) ... Continue reading →

As the biopharmaceutical industry continues to expand at a rapid pace, many manufacturers are grappling with a variety of challenges, particularly regarding the complexities of in-house manufacturing. A significant barrier is the recurring issue of insufficient expertise and outdated or inadequate equipment, which can hinder production efficiency and innovation. Consequently, many emerging biopharmaceutical companies, often in their early development stages, are heavily reliant on external funding and contract manufacturing organizations (CMOs) to navigate these challenges. These biotech companies generally lack the robust capability to establish comprehensive and efficient manufacturing operations, positioning CMOs as vital partners in their journey to market. The competitive landscape among established CMOs, such as Lonza and Boehringer Ingelheim, has intensified significantly. They now face competition not only from seasoned industry players but also from a surge of emerging CMOs ... Continue reading →

According to FutureWise analysis the market for Biopharmaceutical Excipients in 2023 was US$ 2.55 billion, and is expected to reach US$ 4.29 billion by 2031 at a CAGR of 6.70%. Biopharmaceutical excipients are inactive substances intentionally incorporated into biopharmaceutical formulations. Their primary role is to enhance the stability, delivery, and overall performance of active biological ingredients, including proteins, monoclonal antibodies, vaccines, and nucleic acids. While excipients do not possess therapeutic effects themselves, they are crucial in ensuring the safety, efficacy, and quality of biopharmaceutical products. The unique properties of biologics present several challenges, as they are often sensitive to environmental conditions such as pH, temperature, and shear stress. To address these challenges, excipients serve various functions, including stabilizing proteins to prevent aggregation or degradation, improving solubility, controlling viscosity, and enhancing ... Continue reading →

According to FutureWise analysis the market for biopharmaceutical fermentation systems in 2023 was US$ 25.22 billion, and is expected to reach US$ 54.26 billion by 2031 at a CAGR of 10.10%. Biopharmaceutical fermentation systems play a crucial role in the production of biologics, including therapeutic proteins, monoclonal antibodies, vaccines, and enzymes. These systems employ microorganisms or mammalian cells to generate complex biomolecules, utilizing controlled environments for cell cultivation. The cells—such as bacteria, yeast, or mammalian cell lines—are often genetically engineered to produce specific biopharmaceutical products. Fermentation is essential in biopharmaceutical manufacturing, facilitating large-scale production of high-value therapeutics that adhere to strict quality and safety regulations. Typically, fermentation systems consist of bioreactors or fermenters designed to create optimal conditions for cell growth and product expression. They achieve this ... Continue reading →

Trigeminal neuralgia is commonly referred to as one of the most unbearable diseases known to medical science. Patients suffering from this condition have sudden bouts of severe facial pain, which are symptoms of a quick trigger, such as talking, eating, or even a light breeze on the face. People used to have very little hope for relief from their pain in the past. Experiments and research on this disease have advanced considerably in Kolkata, one of the prime cities in India for this purpose. The Challenge of Trigeminal Neuralgia Trigeminal Neuralgia Kolkata involves the trigeminal nerve, which is a nerve that allows the brain to receive sensations from the face. The affected nerve can cause the patient to suffer from repeated attacks of severe pain that can last for seconds but often recur many times a day. Medication traditionally used in the treatment of this disorder usually provides only temporary relief. But then this is where a medical team from the city of Kolkata comes ... Continue reading →

When replacing missing teeth, two of the most common options are dental implants and dental bridges. On the surface, both provide functional and cosmetic solutions, but the differences go well beyond appearance or initial cost. Understanding these distinctions helps patients choose the option that best supports their long-term oral health. How Dental Bridges Work A bridge fills a gap by anchoring an artificial tooth (or several) to the neighbouring teeth. This usually requires reshaping healthy teeth on either side so they can support the structure. While bridges are less invasive and generally quicker to complete, they place added pressure on adjacent teeth, which can lead to wear or damage over time. How Dental Implants Work Dental implants take a different approach. A titanium post is inserted into the jawbone, where it fuses with the bone to act as an artificial tooth root. A crown is then attached, designed to match the natural teeth. Implants don’t rely on surrounding ... Continue reading →